The Insomnia Severity Index: Psychometric Indicators to Detect Insomnia Cases and Evaluate Treatment Response

Overview

Journal Sleep

Publisher Oxford University Press

Specialty Psychiatry

Date 2011 May 3

PMID 21532953

Citations 1674

Authors

Charles M Morin

Genevieve Belleville

Lynda Belanger

Hans Ivers

Affiliations

Soon will be listed here.

Abstract

Background: Although insomnia is a prevalent complaint with significant morbidity, it often remains unrecognized and untreated. Brief and valid instruments are needed both for screening and outcome assessment. This study examined psychometric indices of the Insomnia Severity Index (ISI) to detect cases of insomnia in a population-based sample and to evaluate treatment response in a clinical sample.

Methods: Participants were 959 individuals selected from the community for an epidemiological study of insomnia (Community sample) and 183 individuals evaluated for insomnia treatment and 62 controls without insomnia (Clinical sample). They completed the ISI and several measures of sleep quality, fatigue, psychological symptoms, and quality of life; those in the Clinical sample also completed sleep diaries, polysomnography, and interviews to validate their insomnia/good sleep status and assess treatment response. In addition to standard psychometric indices of reliability and validity, item response theory analyses were computed to examine ISI item response patterns. Receiver operating curves were used to derive optimal cutoff scores for case identification and to quantify the minimally important changes in relation to global improvement ratings obtained by an independent assessor.

Results: ISI internal consistency was excellent for both samples (Cronbach α of 0.90 and 0.91). Item response analyses revealed adequate discriminatory capacity for 5 of the 7 items. Convergent validity was supported by significant correlations between total ISI score and measures of fatigue, quality of life, anxiety, and depression. A cutoff score of 10 was optimal (86.1% sensitivity and 87.7% specificity) for detecting insomnia cases in the community sample. In the clinical sample, a change score of -8.4 points (95% CI: -7.1, -9.4) was associated with moderate improvement as rated by an independent assessor after treatment.

Conclusion: These findings provide further evidence that the ISI is a reliable and valid instrument to detect cases of insomnia in the population and is sensitive to treatment response in clinical patients.

Citing Articles

Determinants of treatment response to cognitive behavioral therapy in veterans presenting with comorbid insomnia and sleep apnea.

El-Solh A, Martinson A, Attai P, Homish G, Aibangbee K, Gould E Sleep Breath. 2025; 29(2):129.

PMID: 40085346 DOI: 10.1007/s11325-025-03298-z.

The role of fatty acids in the emotional well-being of young adults: associations between fatty acid levels and symptoms of depression, anxiety, stress, and sleep disturbances.

Karakula-Juchnowicz H, Banaszek A, Sitarz R, Karakula K, Wingralek Z, Rzad Z Postep Psychiatr Neurol. 2025; 33(1):201-212.

PMID: 40070427 PMC: 11891755. DOI: 10.5114/ppn.2024.144224.

The association between quality of life and psychological flexibility, depressive, anxiety or insomnia symptoms in patients with persistent indoor environment-related symptoms or chronic fatigue.

Selinheimo S, Vuokko A, Lappalainen P, Keinonen K, Sainio M, Lappalainen R BMC Psychol. 2025; 13(1):229.

PMID: 40069901 PMC: 11900652. DOI: 10.1186/s40359-025-02549-8.

The relationship between negative emotions and adjustment disorder in young adults: the mediating role of rumination and insomnia.

Shao X, Dong Z, Zhang S, Qiao Y, Zhang H, Guo H Front Psychiatry. 2025; 16:1474108.

PMID: 40066135 PMC: 11891341. DOI: 10.3389/fpsyt.2025.1474108.

An Evaluation of Time Spent Completing Electronically Collected Patient-Reported Outcomes in Clinical Trials.

Andersen L, Williams M, Pease S, Dhatt H, Delong P Ther Innov Regul Sci. 2025; .

PMID: 40056370 DOI: 10.1007/s43441-025-00767-1.

References

Buysse D, Ancoli-Israel S, Edinger J, Lichstein K, Morin C . Recommendations for a standard research assessment of insomnia. Sleep. 2006; 29(9):1155-73. DOI: 10.1093/sleep/29.9.1155. View

Breslau N, Roth T, Rosenthal L, Andreski P . Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol Psychiatry. 1996; 39(6):411-8. DOI: 10.1016/0006-3223(95)00188-3. View

Roth T . Prevalence, associated risks, and treatment patterns of insomnia. J Clin Psychiatry. 2005; 66 Suppl 9:10-3. View

Soldatos C, Dikeos D, Paparrigopoulos T . Athens Insomnia Scale: validation of an instrument based on ICD-10 criteria. J Psychosom Res. 2000; 48(6):555-60. DOI: 10.1016/s0022-3999(00)00095-7. View

Sheu C, Chen C, Su Y, Wang W . Using SAS PROC NLMIXED to fit item response theory models. Behav Res Methods. 2005; 37(2):202-18. DOI: 10.3758/bf03192688. View

Ohayon M, Roth T . Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res. 2002; 37(1):9-15. DOI: 10.1016/s0022-3956(02)00052-3. View

Yang M, Morin C, Schaefer K, Wallenstein G . Interpreting score differences in the Insomnia Severity Index: using health-related outcomes to define the minimally important difference. Curr Med Res Opin. 2009; 25(10):2487-94. DOI: 10.1185/03007990903167415. View

Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M . Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med. 2008; 4(5):487-504. PMC: 2576317. View

Smets E, Garssen B, Bonke B, de Haes J . The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995; 39(3):315-25. DOI: 10.1016/0022-3999(94)00125-o. View

10.

Morin C . Measuring outcomes in randomized clinical trials of insomnia treatments. Sleep Med Rev. 2003; 7(3):263-79. DOI: 10.1053/smrv.2002.0274. View

11.

Morin C, LeBlanc M, Daley M, Gregoire J, Merette C . Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006; 7(2):123-30. DOI: 10.1016/j.sleep.2005.08.008. View

12.

Simon G, VonKorff M . Prevalence, burden, and treatment of insomnia in primary care. Am J Psychiatry. 1997; 154(10):1417-23. DOI: 10.1176/ajp.154.10.1417. View

13.

Spielman A, Saskin P, Thorpy M . Treatment of chronic insomnia by restriction of time in bed. Sleep. 1987; 10(1):45-56. View

14.

Savard M, Savard J, Simard S, Ivers H . Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncology. 2004; 14(6):429-41. DOI: 10.1002/pon.860. View

15.

Morin C, Vallieres A, Guay B, Ivers H, Savard J, Merette C . Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial. JAMA. 2009; 301(19):2005-15. PMC: 3050624. DOI: 10.1001/jama.2009.682. View

16.

Ware Jr J, Kosinski M, Keller S . A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34(3):220-33. DOI: 10.1097/00005650-199603000-00003. View

17.

Buysse D, Reynolds 3rd C, Monk T, BERMAN S, Kupfer D . The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989; 28(2):193-213. DOI: 10.1016/0165-1781(89)90047-4. View

18.

Ohayon M . Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2003; 6(2):97-111. DOI: 10.1053/smrv.2002.0186. View

19.

Ozminkowski R, Wang S, Walsh J . The direct and indirect costs of untreated insomnia in adults in the United States. Sleep. 2007; 30(3):263-73. DOI: 10.1093/sleep/30.3.263. View

20.

Moul D, Hall M, Pilkonis P, Buysse D . Self-report measures of insomnia in adults: rationales, choices, and needs. Sleep Med Rev. 2004; 8(3):177-98. DOI: 10.1016/S1087-0792(03)00060-1. View